6294-04-8

4-{[2-(2,4-dichlorophenoxy)propanoyl]amino}-2-hydroxybenzoic acid

4-{[2-(2,4-dichlorophenoxy)propanoyl]amino}-2-hydroxybenzoic acid

Catalog No.2360032
Name 4-{[2-(2,4-dichlorophenoxy)propanoyl]amino}-2-hydroxybenzoic acid
CAS6294-04-8
FormulaC16H13Cl2NO5
Boiling Point326 ( ℃ )

Request a Quote

Structure of 6294-04-8

About 4-{[2-(2,4-dichlorophenoxy)propanoyl]amino}-2-hydroxybenzoic acid

4-{[2-(2,4-dichlorophenoxy)propanoyl]amino}-2-hydroxybenzoic acid is a chemical compound registered under CAS number 6294-04-8, with the molecular formula C16H13Cl2NO5 and a molecular weight of about 370.18 g/mol. KingPharm Group supplies 4-{[2-(2,4-dichlorophenoxy)propanoyl]amino}-2-hydroxybenzoic acid for laboratory research and bulk production; product code 2360032. Send an inquiry for purity, packaging, price and lead time.

CAS Number
6294-04-8
Molecular Formula
C16H13Cl2NO5
Molecular Weight
370.18 g/mol

Related Products

  1. Phosphonic acid, [[5-cyano-2-(2-methylpropyl)-3-furanyl]methyl]-, diethylester
    884588-39-0
  2. Uridine, 3'-decanoate 2',5'-dimethanesulfonate
    661455-92-1
  3. Methanimidamide, N'-(4-methylphenyl)-N-phenyl-, N'-oxide
    63553-22-0
  4. Benzonitrile, 2-fluoro-5-(hydroxymethyl)-4-(methoxymethoxy)-
    162270-08-8
  5. Morpholine, 4-[(6-methyl-3-cyclohexen-1-yl)carbonyl]-
    56049-94-6
  6. 7(4H)-Benzothiazolone, 5,6-dihydro-5-(1-methylethyl)-2-(4-morpholinyl)-
    913716-62-8
  7. Benzenesulfonamide,3,4,5-trimethoxy-N-(1-methyl-1H-benzimidazol-5-yl)-
  8. Benzoic acid, 3-[[(4-nitrophenoxy)carbonyl]amino]-, methyl ester
  9. 5-Benzoxazolol, 2-(6-hydroxy-2-naphthalenyl)-
  10. 2,4(1H,3H)-Quinazolinedione,6-chloro-3-[1-(6,7-dimethoxy-4-quinazolinyl)-4-piperidinyl]-1-ethyl-
  11. 6294-04-8 msds
  12. CAS No 6294-04-8 supplier
  13. CASNo 6294-04-8 distributor
  14. CAS # 6294-04-8 manufacturer
  15. CAS Number 6294-04-8 safety
  16. CAS RN 6294-04-8 wholesale
  17. 2026-10-26 Find 4-{[2-(2,4-dichlorophenoxy)propanoyl]amino}-2-hydroxybenzoic acid,CAS No.6294-04-8,Formula:C16H13Cl2NO5 in KingPharm Group